Pushing the reset button: Chemical-induced conversion of amniotic fluid stem cells into a pluripotent state

Molecular Therapy

Volumn 20, Issue 10, 2012, Pages 1839-1841

  Diecke, Sebastian ^a   Wu, Joseph C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BUTYRIC ACID; TRICHOSTATIN A; VALPROIC ACID; VORINOSTAT;

AMNIOTIC FLUID CELL; CELL DIFFERENTIATION; CELL TYPE; DNA METHYLATION; EMBRYONIC STEM CELL; EPIGENETICS; FIBROBLAST; GENOME; HUMAN; MUTAGENICITY; NONHUMAN; NOTE; PHENOTYPIC PLASTICITY; PLURIPOTENT STEM CELL; SPERMATOGENESIS; STROMA CELL; TRANSGENE;

EID: 84866898643     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2012.192     Document Type: Note

References (22)

1. Moschidou, D, Mukherjee, S, Blundell, M P, Drews, K, Jones, GN, Abdulrazzak, H et al. (2012). Valproic acid confers functional pluripotency to human am-niotic fuid stem cells in a transgene-free approach. Mol Ther 20: 1953-1967.
2. Takahashi, K and Yamanaka, S (2006). Induction of pluripotent stem cells from mouse embryonic and adult fbroblast cultures by defned factors. Cell 126: 663-676.
3. Takahashi, K, Tanabe, K, Ohnuki, M, Narita, M, Ichisaka, T, Tomoda, K et al. (2007). Induction of pluripotent stem cells from adult human fbroblasts by defned factors. Cell 131: 861-872.
4. Takahashi, K, Okita, K, Nakagawa, M and Yamanaka, S (2007). Induction of pluripotent stem cells from fbroblast cultures. Nat Protoc 2: 3081-3089.
5. Yu, J, Vodyanik, MA, Smuga-Otto, K, Antosiewicz-Bourget, J, Frane, JL, Tian, S et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.
6. Stadtfeld, M, Nagaya, M, Utikal, J, Weir, G and Hochedlinger, K (2008). Induced pluripotent stem cells generated without viral integration. Science 322: 945-949.
7. Warren, L, Manos, PD, Ahfeldt, T, Loh, YH, Li, H, Lau, F et al. (2010). Highly effcient reprogramming to pluripotency and directed differentiation of human cells with synthetic modifed mRNA. Cell Stem Cell 7: 618-630.
8. Jia, F, Wilson, KD, Sun, N, Gupta, DM, Huang, M, Li, Z et al. (2010). A nonviral minicircle vector for deriving human iPS cells. Nat Methods 7: 197-199.
9. Amabile, G and Meissner A (2009). Induced pluripo-tent stem cells: current progress and potential for regenerative medicine. Trends Mol Med 15: 59-68.
10. Li, W, Wei, W, Zhu, S, Zhu, J, Shi, Y, Lin, T et al. (2009). Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell 4: 16-19.
11. Sun, N, Panetta, NJ, Gupta, DM, Wilson, KD, Lee, A, Jia, F et al. (2009). Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci USA 106: 15720-15725.
12. Kim, JB, Zaehres, H, Wu, G, Gentile, L, Ko, K, Sebas-tiano, V et al. (2008). Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 454: 646-650.
13. De Coppi, P, Bartsch, G Jr, Siddiqui, MM, Xu, T, Santos, CC, Perin, L et al. (2007). Isolation of am-niotic stem cell lines with potential for therapy. Nat Biotechnol 25: 100-106.
14. Kretsovali, A, Hadjimichael, C and Charmpilas, N (2012). Histone deacetylase inhibitors in cell pluri-potency, differentiation, and reprogramming. Stem Cells Int 2012: 184154.
15. Nichols, J and Smith, A (2009). Naive and primed pluripotent states. Cell Stem Cell 4: 487-492.
16. Han, J, Sachdev, PS and Sidhu, KS (2010). A combined epigenetic and non-genetic approach for reprogramming human somatic cells. PloS One 5: e12297.
17. Guan, X, Delo, DM, Atala, A and Soker, S (2011). In vitro cardiomyogenic potential of human amniotic fuid stem cells. J Tissue Eng Regen Med 5: 220-228.
18. Galende, E, Karakikes, I, Edelmann, L, Desnick, RJ, Kerenyi, T, Khoueiry, G et al. (2010). Amniotic fuid cells are more effciently reprogrammed to pluripo-tency than adult cells. Cell Reprogram 12: 117-125.
19. Nettersheim, D, Gillis, A, Biermann, K, Looijenga, LH and Schorle, H (2011). The seminoma cell line TCam-2 is sensitive to HDAC inhibitor depsipeptide but tolerates various other chemotherapeutic drugs and loss of NANOG expression. Genes Chromosomes Cancer 50: 1033-1042.
20. Shamblott, MJ, Axelman, J, Wang, S, Bugg, EM, Littlefeld, JW, Donovan, PJ et al. (1998). Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci USA 95: 13726-13731.
21. Buzzard, JJ, Gough, NM, Crook, JM and Colman, A (2004). Karyotype of human ES cells during extended culture. Nat Biotechnol 22: 381-382; author reply 382.
22. Taylor, CJ, Bolton, EM, Pocock, S, Sharples, LD, Pedersen, RA and Bradley, JA (2005). Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching. Lancet 366: 2019-2025.